| scholarly article | Q13442814 |
| P2093 | author name string | Fengling Li | |
| Lin Li | |||
| Hui Tian | |||
| Shuhai Li | |||
| Weiming Yue | |||
| Guanqing Chen | |||
| P2860 | cites work | Characterization of two receptors for TRAIL | Q24309064 |
| Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis | Q24797571 | ||
| Multilineage potential of adult human mesenchymal stem cells | Q27860737 | ||
| Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors | Q28245164 | ||
| Identification of the haematopoietic stem cell niche and control of the niche size | Q29615008 | ||
| Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells | Q29618766 | ||
| Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma | Q32033905 | ||
| Bortezomib sensitizes human esophageal squamous cell carcinoma cells to TRAIL-mediated apoptosis via activation of both extrinsic and intrinsic apoptosis pathways | Q33907593 | ||
| Targeted induction of apoptosis in cancer management: the emerging role of tumor necrosis factor-related apoptosis-inducing ligand receptor activating agents | Q36345472 | ||
| Delivery of sTRAIL variants by MSCs in combination with cytotoxic drug treatment leads to p53-independent enhanced antitumor effects | Q37073589 | ||
| Mesenchymal stem cells expressing TRAIL lead to tumour growth inhibition in an experimental lung cancer model | Q37310677 | ||
| Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy | Q39245228 | ||
| Effective combination therapy for malignant glioma with TRAIL-secreting mesenchymal stem cells and lipoxygenase inhibitor MK886. | Q39282411 | ||
| Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. | Q39737918 | ||
| Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer. | Q39852557 | ||
| AAV-encoded expression of TRAIL in experimental human colorectal cancer leads to tumor regression. | Q40582634 | ||
| Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. | Q44022873 | ||
| Value of radiotherapy after radical surgery for esophageal carcinoma: a report of 495 patients. | Q53395748 | ||
| Esophageal Cancer | Q56209683 | ||
| Apoptosis mediated by lentiviral TRAIL transfer involves transduction-dependent and -independent effects | Q57384572 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | esophageal cancer | Q372701 |
| Adenoviridae | Q193447 | ||
| cancer cell line | Q23058136 | ||
| P304 | page(s) | 471-476 | |
| P577 | publication date | 2014-04-15 | |
| P1433 | published in | Acta Biochimica et Biophysica Sinica | Q2183997 |
| P1476 | title | Human mesenchymal stem cells with adenovirus-mediated TRAIL gene transduction have antitumor effects on esophageal cancer cell line Eca-109. | |
| P478 | volume | 46 |
| Q52608756 | Application of Mesenchymal Stem Cells for Therapeutic Agent Delivery in Anti-tumor Treatment. | cites work | P2860 |
Search more.